Skip to main content
. 2017 Oct 17;8(61):103327–103339. doi: 10.18632/oncotarget.21872

Figure 6. Analysis of the prognostic impact of each single signature gene.

Figure 6

(A) Kaplan–Meier curves for patients in SRPK1 high and low-expression groups. (B) Kaplan–Meier curves for patients in PCAA high and low-expression groups. (C) Kaplan–Meier curves for patients in PRLR high and low-expression groups. (D) Kaplan–Meier curves for patients in FBP1 high and low-expression groups.